Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
817
-
Total shares
-
38.5M
-
Shares change
-
-1.55M
-
Total reported value, excl. options
-
$4.71B
-
Value change
-
-$193M
-
Put/Call ratio
-
3.88
-
Number of buys
-
220
-
Number of sells
-
-383
-
Price
-
$122.29
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2023
838 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q3 2023.
ISHARES TR - ISHARES BIOTECH (IBB) has 817 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.5M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (9.68M shares), MORGAN STANLEY (2.93M shares), GOLDMAN SACHS GROUP INC (2.42M shares), CITIGROUP INC (2.33M shares), JPMORGAN CHASE & CO (1.84M shares), UBS Group AG (1.42M shares), BNP PARIBAS ARBITRAGE, SNC (1.42M shares), Royal Bank of Canada (1.2M shares), COMMERCE BANK (724K shares), and WELLS FARGO & COMPANY/MN (673K shares).
This table shows the top 817 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.